Tue, August 10, 2021

Salveen Richter Downgraded (BLUE) to Hold and Decreased Target to $23 on, Aug 10th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-23-on-aug-10th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Salveen Richter of Goldman Sachs, Downgraded "bluebird bio, Inc." (BLUE) to Hold and Decreased Target from $63 to $23 on, Aug 10th, 2021.

Salveen has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, all agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $35 on, Friday, July 16th, 2021
  • Yun Zhong of "Berenberg" Downgraded from Strong Buy to Hold and Held Target at $35 on, Thursday, July 1st, 2021